MARKET

PKI

PKI

PerkinElmer
NYSE

Real-time Quotes | Nasdaq Last Sale

151.55
-3.10
-2.00%
After Hours: 151.00 -0.55 -0.36% 17:20 06/24 EDT
OPEN
155.82
PREV CLOSE
154.65
HIGH
156.59
LOW
149.54
VOLUME
1.19M
TURNOVER
--
52 WEEK HIGH
162.70
52 WEEK LOW
93.23
MARKET CAP
16.99B
P/E (TTM)
15.86
1D
5D
1M
3M
1Y
5Y
PerkinElmer Inc. stock falls Thursday, underperforms market
marketwatch.com · 1h ago
PerkinElmer on track to snap winning streak on lower-than-expected guidance
TheCrimsonRibbon/iStock via Getty Images PerkinElmer ([[PKI]] -1.8%) is set to record its first intra-day loss in more than two weeks after the company’s 2023 guidance came below expectations. On its
Seekingalpha · 3h ago
PerkinElmer foresees 2Q21 earnings to be above the prior guidance
PerkinElmer (PKI) expects to beat prior Q2 guidance of $2.35 and $1.11 billion in revenue vs. a consensus EPS of $2.44 and $1.12 billion in revenue.PerkinElmer will release its Q2
Seekingalpha · 11h ago
PerkinElmer Sees 2Q Revenue, Earnings Above Previous Guidance
marketwatch.com · 12h ago
BRIEF-PerkinElmer Inc - Anticipates Q2 Revenue And Earnings To Be Above Previously Communicated Guidance
reuters.com · 12h ago
PerkinElmer Provides Update on Second Quarter Performance and Schedules Earnings Call for Wednesday, July 28, 2021
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced ahead of this morning's Virtual Investor and Analyst Day that it anticipates exceeding its previously announced financial guidance for the second ...
Business Wire · 12h ago
PerkinElmer Says Expects to Exceed Q2 Guidance
MT Newswires · 15h ago
PerkinElmer Inc. stock outperforms competitors on strong trading day
marketwatch.com · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PKI. Analyze the recent business situations of PerkinElmer through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PKI stock price target is 159.71 with a high estimate of 193.00 and a low estimate of 135.00.
EPS
Institutional Holdings
Institutions: 749
Institutional Holdings: 118.70M
% Owned: 105.90%
Shares Outstanding: 112.09M
TypeInstitutionsShares
Increased
200
7.13M
New
74
1.37M
Decreased
203
7.46M
Sold Out
81
499.37K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.09%
Healthcare Equipment & Supplies
+0.04%
Key Executives
Non-Executive Chairman/Independent Director
Alexis Michas
Non-Executive Chairman/Independent Director
Alexandros Michas
President/Chief Executive Officer/Director
Prahlad Singh
Chief Financial Officer/Senior Vice President
James Mock
Senior Vice President/General Counsel/Secretary
Joel Goldberg
Senior Vice President
Daniel Tereau
Senior Vice President
Miriame Victor
Senior Vice President
Tajinder Vohra
Chief Accounting Officer/Vice President/Treasurer
Andrew Okun
Independent Director
Peter Barrett
Independent Director
Samuel Chapin
Independent Director
Sylvie Gregoire
Independent Director
Michel Vounatsos
Independent Director
Frank Witney
Independent Director
Pascale Witz
Independent Director
Franklin Witney
Declaration Date
Dividend Per Share
Ex-Div Date
04/29/2021
Dividend USD 0.07
07/15/2021
01/28/2021
Dividend USD 0.07
04/15/2021
10/22/2020
Dividend USD 0.07
01/21/2021
07/23/2020
Dividend USD 0.07
10/15/2020
04/30/2020
Dividend USD 0.07
07/16/2020
01/23/2020
Dividend USD 0.07
04/16/2020
10/24/2019
Dividend USD 0.07
01/16/2020
07/25/2019
Dividend USD 0.07
10/17/2019
04/25/2019
Dividend USD 0.07
07/18/2019
01/24/2019
Dividend USD 0.07
04/17/2019
10/24/2018
Dividend USD 0.07
01/17/2019
07/23/2018
Dividend USD 0.07
10/18/2018
04/26/2018
Dividend USD 0.07
07/19/2018
01/25/2018
Dividend USD 0.07
04/12/2018
10/27/2017
Dividend USD 0.07
01/18/2018
07/25/2017
Dividend USD 0.07
10/19/2017
05/01/2017
Dividend USD 0.07
07/19/2017
01/27/2017
Dividend USD 0.07
04/11/2017
10/27/2016
Dividend USD 0.07
01/18/2017
07/28/2016
Dividend USD 0.07
10/12/2016
About PKI
PerkinElmer Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. Its Discovery & Analytical Solutions segment serves the life sciences and applied markets. Through the Diagnostics Segment, it offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals. It provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its product under various brands, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, FragilEase, Genoglyphix, GSP, PG-Seq, PG-Find, Protein Clear, ProteinEXact and QSight, Glutomatic, Honigs Regression, HyperDSC, Inframatic, LAMBDA, NexION, NEN, OneSource, Opera Phenix, Operetta CLS and OsteoSense.

Webull offers kinds of PerkinElmer, Inc. stock information, including NYSE:PKI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PKI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PKI stock methods without spending real money on the virtual paper trading platform.